Medicine and HealthNot specified in provided text
Emerging heterologous mRNA-based booster strategies within the COVID-19 vaccine landscape
R. Das, R. N. Hyer, et al.
Discover how heterologous mRNA-based boosting strategies hold promise against emerging SARS-CoV-2 variants. This insightful review by Rituparna Das and colleagues sheds light on innovative approaches that could significantly mitigate the impact of COVID-19.
Related Publications
Explore these studies to deepen your understanding
Adjacent work that informs or extends this paper's methodology and findings.
Medicine and Health
The BNT162b2 mRNA COVID-19 Vaccine Increases the Contractile Sensitivity to Histamine and Parasympathetic Activation in a Human Ex Vivo Model of Severe Eosinophilic Asthma
A. Caputo, F. Nicoli, et al.
Medicine and Health
Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes
R. Grewal, L. Nguyen, et al.
Business
Hollywood survival strategies in the post-COVID 19 era
M. J. Jr
Medicine and Health
mRNA melanoma vaccine revolution spurred by the COVID-19 pandemic
Z. Xu and D. E. Fisher
